Top news from MedWatch this week

Monday
Over-the-counter hearing aids didn’t disrupt the market – but raised awareness of hearing loss
Hearing aids sold over the counter off to sluggish start, says GN Hearing
Eli Lilly to initiate head-to-head study against Novo Nordisk’s Wegovy
Genmab appeals arbitration defeat against Janssen
Tuesday
Novo Nordisk and Eli Lilly lobby US Congress for Medicare coverage of obesity drugs
Abacus to speed up new business leg leveraging upcoming EU drug law
Wednesday
GN Hearing raises outlook for the year
EU’s massive pharma reform targets drug assessments within 180 days at most
Analyst hopes for news about GN’s capital structure in first-quarter report
Thursday
Pharma industry taking to the barricades after presented extensive EU pharma reform
Novo Nordisk CEO on EU pharma reform: ”The stupidest thing I’ve heard”
Friday
GN Hearing CEO: R&D won’t suffer under new debt financing plan